In a noteworthy announcement, 10X Capital Venture Acquisition Corp. III (referred to as 10X III in this article), confirmed that it has received non-compliance notice from the New York Stock Exchange (NYSE) Regulation, Inc. due to its delay in filing the Form 10-K annual financial report. The document was due for submission on April 16, 2024, as per NYSE American LLC’s (NYSE American) continued listing standards.
Based in New York, 10X III operates under the stock symbol VCXB on the NYSE American. This situation ignited when the company failed to file its Annual Report on Form 10-K for the fiscal year that concluded on December 31, 2023, on time. The late filing has led to the company’s placement in a spot of hot water with the NYSE. According to the letter from the NYSE, received by 10X III on April 17, 2024, the delay put the company out of sync with NYSE American’s continued listing standards.
Delving deeper into the reasons for the delay, the primary issue that hindered the timely filing of the annual report was the extended time the independent registered public accounting firm required for completing its review of 10X III’s financial statements for 2023. Unfortunately, the delay in the extensive and detailed financial review resulted in the subsequent impasse with NYSE compliance deadlines.
The Annual Report underwent an in-depth examination involving intensive audits by external independent registered public accounting firms. The process validates the respective company’s financial transactions and statements, ensuring compliance with the Generally Accepted Accounting Principles (GAAP). Hence, any delay in this crucial audit affects the subsequent legal and regulatory filings that companies like 10X III need to comply with on a strict timeline, as in this case.
For 10X Capital Venture Acquisition Corp. III, the situation is indeed a setback, coming under the regulatory scrutiny of NYSE. Nevertheless, it is essential to remember that the delays in such processes are not unheard of, given the rigorous checking and validation processes involved. Undoubtedly, the situation demands urgent attention, and it will be worthwhile to see how 10X IIIs responds to the situation to regain its compliance with the NYSE’s continued listing standards.
Considering that 10X III is a listed company on the NYSE American, stakeholders and the financial community will be eagerly waiting for the firm’s 2023 annual report. Demonstrating transparency and regulatory compliance in its financial disclosures will be paramount in maintaining the investors’ trust.
Given these circumstances, the company’s next steps will be under keen observation, and how it maneuvers through the process will play a significant role in shaping its image in the eyes of its investors and the market on a broader scale.
Comments